Skip to main content
Erschienen in: Neurotherapeutics 2/2013

01.04.2013 | Review

Neuroimaging in Mitochondrial Disorders

verfasst von: Andrea L. Gropman

Erschienen in: Neurotherapeutics | Ausgabe 2/2013

Einloggen, um Zugang zu erhalten

Summary

Mutations in either nuclear DNA or mitochondrial DNA can result in disruption of oxidative phosphorylation and lead to mitochondrial dysfunction. Mitochondrial disease manifestations occur predominantly in the central nervous system, peripheral nervous system, and/or involve several organ systems. The consequences range from manifestations of a single organ or tissues, such as muscle fatigue, if confined only to muscle, seizures, intellectual disabilities, dementia, and stroke (if to the central nervous system), leading to disability or even early death. The definitive diagnosis of a mitochondrial disorder can be difficult to establish. Criteria and checklists have been established and are more reflective of adult disease. However, in children, when symptoms suggest a mitochondrial disease, neuroimaging features may have more diagnostic impact and additionally these can be used to follow the course, evolution, and recovery of the disease. This review will demonstrate the common neuroimaging patterns in patients with mitochondrial disorders and point out how various newer neuroimaging modalities may be exploited to glean information as to the different aspects of mitochondrial dysfunction or resulting neurological and cognitive disruption, although reports in the literature using these methods remain sparse.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Wallace DC, Fan W, Procaccio V. Mitochondrial energetics and therapeutics. Annu Rev Pathol Mech Dis 2010;5:297–348.CrossRef Wallace DC, Fan W, Procaccio V. Mitochondrial energetics and therapeutics. Annu Rev Pathol Mech Dis 2010;5:297–348.CrossRef
2.
Zurück zum Zitat DiMauro S. Mitochondrial medicine. Biochim Biophys Acta 2004;1658:107–114. DiMauro S. Mitochondrial medicine. Biochim Biophys Acta 2004;1658:107–114.
3.
Zurück zum Zitat Thorburn DR. Mitochondrial disorders: prevalence, myths, and advances. J Inherit Metab Dis 2004;27:349–362.PubMedCrossRef Thorburn DR. Mitochondrial disorders: prevalence, myths, and advances. J Inherit Metab Dis 2004;27:349–362.PubMedCrossRef
4.
Zurück zum Zitat Anderson S, Bankier AT, Barrell BG, de Bruijn MH, et al. Sequence and organization of the human mitochondrial genome. Nature 1981;290:457–465.PubMedCrossRef Anderson S, Bankier AT, Barrell BG, de Bruijn MH, et al. Sequence and organization of the human mitochondrial genome. Nature 1981;290:457–465.PubMedCrossRef
5.
6.
Zurück zum Zitat Gropman AL. The neurological presentations of childhood and adult mitochondrial disease: established syndromes and phenotypic variations. Mitochondrion 2004;4:503–520.PubMedCrossRef Gropman AL. The neurological presentations of childhood and adult mitochondrial disease: established syndromes and phenotypic variations. Mitochondrion 2004;4:503–520.PubMedCrossRef
7.
Zurück zum Zitat Brunetti-Pierri N, Selby K, O'Sullivan M, et al. Rapidly progressive neurological deterioration in a child with Alpers syndrome exhibiting a previously unremarkable brain MRI. Neuropediatrics 2008;39:179–183.PubMedCrossRef Brunetti-Pierri N, Selby K, O'Sullivan M, et al. Rapidly progressive neurological deterioration in a child with Alpers syndrome exhibiting a previously unremarkable brain MRI. Neuropediatrics 2008;39:179–183.PubMedCrossRef
8.
9.
Zurück zum Zitat Friedman SD, Shaw DW, Ishak G, Gropman AL, Saneto RP. The use of neuroimaging in the diagnosis of mitochondrial disease. Dev Disabil Res Rev 2010;16:129–135.PubMedCrossRef Friedman SD, Shaw DW, Ishak G, Gropman AL, Saneto RP. The use of neuroimaging in the diagnosis of mitochondrial disease. Dev Disabil Res Rev 2010;16:129–135.PubMedCrossRef
10.
Zurück zum Zitat Masucci JP, Schon EA, King MP. Point mutations in the mitochondrial tRNA(Lys) gene: implications for pathogenesis and mechanism. Mol Cell Biochem 1997;174:215–219.PubMedCrossRef Masucci JP, Schon EA, King MP. Point mutations in the mitochondrial tRNA(Lys) gene: implications for pathogenesis and mechanism. Mol Cell Biochem 1997;174:215–219.PubMedCrossRef
11.
12.
Zurück zum Zitat Gropman AL. Expanding the diagnostic and research toolbox for inborn errors of metabolism: the role of magnetic resonance spectroscopy. Mol Genet Metab 2005;86:2–9.PubMed Gropman AL. Expanding the diagnostic and research toolbox for inborn errors of metabolism: the role of magnetic resonance spectroscopy. Mol Genet Metab 2005;86:2–9.PubMed
13.
Zurück zum Zitat Gelfand JM, Duncan JL, Racine CA, et al. Heterogeneous patterns of tissue injury in NARP syndrome. J Neurol 2011;258:440–448.PubMedCrossRef Gelfand JM, Duncan JL, Racine CA, et al. Heterogeneous patterns of tissue injury in NARP syndrome. J Neurol 2011;258:440–448.PubMedCrossRef
14.
Zurück zum Zitat Basser PJ, Mattiello J, LeBihan D. MR diffusion tensor spectroscopy and imaging. Biophys J 1994;66:259–267.PubMedCrossRef Basser PJ, Mattiello J, LeBihan D. MR diffusion tensor spectroscopy and imaging. Biophys J 1994;66:259–267.PubMedCrossRef
15.
Zurück zum Zitat Basser PJ, Pierpaoli C. Microstructural and physiological features of tissues elucidated by quantitative-diffusion-tensor MRI. J Magn Reson B 1996;111:209–219.PubMedCrossRef Basser PJ, Pierpaoli C. Microstructural and physiological features of tissues elucidated by quantitative-diffusion-tensor MRI. J Magn Reson B 1996;111:209–219.PubMedCrossRef
17.
Zurück zum Zitat Guye M, Bartolomei F, Ranjeva JP. Imaging structural and functional connectivity: towards a unified definition of human brain organization? Curr Opin Neurol 2008;21:393–403.PubMedCrossRef Guye M, Bartolomei F, Ranjeva JP. Imaging structural and functional connectivity: towards a unified definition of human brain organization? Curr Opin Neurol 2008;21:393–403.PubMedCrossRef
18.
Zurück zum Zitat Iwata O, Iwata S, Tamura M, et al. Periventricular low intensities on fluid attenuated inversion recovery imaging in the newborn infant: Relationships to chronic white matter lesions. Pediatr Int 2004;46:141–149.PubMedCrossRef Iwata O, Iwata S, Tamura M, et al. Periventricular low intensities on fluid attenuated inversion recovery imaging in the newborn infant: Relationships to chronic white matter lesions. Pediatr Int 2004;46:141–149.PubMedCrossRef
19.
Zurück zum Zitat Maillard P, Carmichael O, Harvey D, et al. FLAIR and Diffusion MRI signals are independent predictors of white matter hyperintensities. AJNR 2012. doi:10.3174/ajnr.A3146. Maillard P, Carmichael O, Harvey D, et al. FLAIR and Diffusion MRI signals are independent predictors of white matter hyperintensities. AJNR 2012. doi:10.​3174/​ajnr.​A3146.
20.
Zurück zum Zitat Hoisington L, Miller RA, Vreibel B. Fast FLAIR techniques in MR imaging of the brain. Radiol Technol 1998;69:351–357.PubMed Hoisington L, Miller RA, Vreibel B. Fast FLAIR techniques in MR imaging of the brain. Radiol Technol 1998;69:351–357.PubMed
21.
Zurück zum Zitat Barkovich AJ, Kjos BO, Jackson DE Jr, Norman D. Normal maturation of the neonatal and infant brain: MR imaging at 1.5 T. Radiology 1988;16:173–180. Barkovich AJ, Kjos BO, Jackson DE Jr, Norman D. Normal maturation of the neonatal and infant brain: MR imaging at 1.5 T. Radiology 1988;16:173–180.
22.
Zurück zum Zitat Roy CS, Sherrington CS. On the regulation of the blood supply of the brain. J Physiol 1890;11:85–108.PubMed Roy CS, Sherrington CS. On the regulation of the blood supply of the brain. J Physiol 1890;11:85–108.PubMed
23.
24.
Zurück zum Zitat Ashburner J, Friston K. Voxel-based morphometry — the methods. NeuroImage 2000;11:805–821.PubMedCrossRef Ashburner J, Friston K. Voxel-based morphometry — the methods. NeuroImage 2000;11:805–821.PubMedCrossRef
25.
Zurück zum Zitat Xu V, Chan H, Lin AP, et al. MR spectroscopy in diagnosis and neurological decision-making. Semin Neurol 2008;28:407–422.PubMedCrossRef Xu V, Chan H, Lin AP, et al. MR spectroscopy in diagnosis and neurological decision-making. Semin Neurol 2008;28:407–422.PubMedCrossRef
26.
Zurück zum Zitat Panigrahy A, Nelson MD Jr, Blüml S. Magnetic resonance spectroscopy in pediatric neuroradiology: clinical and research applications. Pediatr Radiol 2010;40:3–30.PubMedCrossRef Panigrahy A, Nelson MD Jr, Blüml S. Magnetic resonance spectroscopy in pediatric neuroradiology: clinical and research applications. Pediatr Radiol 2010;40:3–30.PubMedCrossRef
27.
Zurück zum Zitat Wilichowski E, Pouwels PJ, Frahm J, Hanefeld. Quantitative proton magnetic resonance spectroscopy of cerebral metabolic disturbances in patients with MELAS. Neuropediatrics 1999;30:256–263.PubMedCrossRef Wilichowski E, Pouwels PJ, Frahm J, Hanefeld. Quantitative proton magnetic resonance spectroscopy of cerebral metabolic disturbances in patients with MELAS. Neuropediatrics 1999;30:256–263.PubMedCrossRef
28.
Zurück zum Zitat Dinopoulos A, Cecil KM, Schapiro MB, et al. Brain MRI and proton MRS findings in infants and children with respiratory chain defects. Neuropediatrics 2005;36:290–301.PubMedCrossRef Dinopoulos A, Cecil KM, Schapiro MB, et al. Brain MRI and proton MRS findings in infants and children with respiratory chain defects. Neuropediatrics 2005;36:290–301.PubMedCrossRef
29.
Zurück zum Zitat Lin DD, Crawford TO, Barker PB. Proton MR spectroscopy in the diagnostic evaluation of suspected mitochondrial disease. AJNR 2003;24:33–41.PubMed Lin DD, Crawford TO, Barker PB. Proton MR spectroscopy in the diagnostic evaluation of suspected mitochondrial disease. AJNR 2003;24:33–41.PubMed
30.
Zurück zum Zitat Abe K, Yoshimura H, Tanaka H, et al. Comparison of conventional and diffusion weighted MRI and proton MR spectroscopy in patients with mitochondrial encephalomyopathy, lactic acidosis, and stroke-like events. Neuroradiology 2004;46:113–117.PubMedCrossRef Abe K, Yoshimura H, Tanaka H, et al. Comparison of conventional and diffusion weighted MRI and proton MR spectroscopy in patients with mitochondrial encephalomyopathy, lactic acidosis, and stroke-like events. Neuroradiology 2004;46:113–117.PubMedCrossRef
31.
Zurück zum Zitat Bianchi MC, Sgandurra G, Tosetti M, et al. Brain magnetic resonance in the diagnostic evaluation of mitochondrial encephalopathies. Biosci Rep 2007;27:69–85.PubMedCrossRef Bianchi MC, Sgandurra G, Tosetti M, et al. Brain magnetic resonance in the diagnostic evaluation of mitochondrial encephalopathies. Biosci Rep 2007;27:69–85.PubMedCrossRef
32.
Zurück zum Zitat Bianchi MC, Tosetti M, Battini R, et al. Proton MR spectroscopy of mitochondrial diseases: analysis of brain metabolic abnormalities and their possible diagnostic relevance. Am J Neuroradiol 2003;24:1958–1966.PubMed Bianchi MC, Tosetti M, Battini R, et al. Proton MR spectroscopy of mitochondrial diseases: analysis of brain metabolic abnormalities and their possible diagnostic relevance. Am J Neuroradiol 2003;24:1958–1966.PubMed
33.
Zurück zum Zitat Pouwels PJ, Brockmann K, Kruse B, et al. Regional age dependence of human brain metabolites from infancy to adulthood as detected by quantitative localized proton MRS. Pediatr Res 1999; 46:474–485.PubMedCrossRef Pouwels PJ, Brockmann K, Kruse B, et al. Regional age dependence of human brain metabolites from infancy to adulthood as detected by quantitative localized proton MRS. Pediatr Res 1999; 46:474–485.PubMedCrossRef
34.
Zurück zum Zitat Bluml S, Seymour KJ, Ross BD. Developmental changes in choline- and ethanolamine-containing compounds measured with proton-decoupled 31PMRS in in-vivo human brain. Magn Reson Med 1999;42:643–654.PubMedCrossRef Bluml S, Seymour KJ, Ross BD. Developmental changes in choline- and ethanolamine-containing compounds measured with proton-decoupled 31PMRS in in-vivo human brain. Magn Reson Med 1999;42:643–654.PubMedCrossRef
35.
Zurück zum Zitat Barkovich AJ, Good WV, Koch TK, Berg BO. Mitochondrial disorders: analysis of their clinical and imaging characteristics. AJNR 1993;14:1119–1137.PubMed Barkovich AJ, Good WV, Koch TK, Berg BO. Mitochondrial disorders: analysis of their clinical and imaging characteristics. AJNR 1993;14:1119–1137.PubMed
36.
Zurück zum Zitat Barragan-Campos HM, Vallee JN, Lo D, et al. Brain magnetic resonance imaging findings in patients with mitochondrial cytopathies. Arch Neurol 2005;62:737–742.PubMedCrossRef Barragan-Campos HM, Vallee JN, Lo D, et al. Brain magnetic resonance imaging findings in patients with mitochondrial cytopathies. Arch Neurol 2005;62:737–742.PubMedCrossRef
37.
Zurück zum Zitat Medina L, Chi TL, DeVivo DC, Hilal SK. MR findings in patients with subacute necrotizing encephalomyelopathy (Leigh syndrome): correlation with biochemical defect. Am J Roentgenol 1990;154:1269–1274.CrossRef Medina L, Chi TL, DeVivo DC, Hilal SK. MR findings in patients with subacute necrotizing encephalomyelopathy (Leigh syndrome): correlation with biochemical defect. Am J Roentgenol 1990;154:1269–1274.CrossRef
38.
Zurück zum Zitat Lee HF, Tsai CR, Chi CS, Lee HJ, Chen CC. Leigh syndrome: clinical and neuroimaging follow-up. Pediatr Neurol 2009;40:88–93.PubMedCrossRef Lee HF, Tsai CR, Chi CS, Lee HJ, Chen CC. Leigh syndrome: clinical and neuroimaging follow-up. Pediatr Neurol 2009;40:88–93.PubMedCrossRef
39.
Zurück zum Zitat Leigh D. Subacute necrotizing encephalomyelopathy in an infant. J Neurol Neurosurg Psychiatry 1951;14:216–221.PubMedCrossRef Leigh D. Subacute necrotizing encephalomyelopathy in an infant. J Neurol Neurosurg Psychiatry 1951;14:216–221.PubMedCrossRef
40.
Zurück zum Zitat Cavanagh JB, Harding BN. Pathogenic factors underlying the lesions in Leigh’s disease. Tissue responses to cellular energy deprivation and their clinico-pathological consequences. Brain 1994;117:1357–1376.PubMedCrossRef Cavanagh JB, Harding BN. Pathogenic factors underlying the lesions in Leigh’s disease. Tissue responses to cellular energy deprivation and their clinico-pathological consequences. Brain 1994;117:1357–1376.PubMedCrossRef
41.
Zurück zum Zitat Leshinsky-Silver E, Lebre AS, Minai L, et al. NDUFS4 mutations cause Leigh syndrome with predominant brainstem involvement. Mol Genet Metab 2009;97:185–189.PubMedCrossRef Leshinsky-Silver E, Lebre AS, Minai L, et al. NDUFS4 mutations cause Leigh syndrome with predominant brainstem involvement. Mol Genet Metab 2009;97:185–189.PubMedCrossRef
42.
Zurück zum Zitat Farina L, Chiapparini L, Uziel G, Bugiani M, Zeviani M, Savoiardo M. MR findings in Leigh syndrome with COX deficiency and SURF-1 mutations. AJNR 2002;23:1095–1100.PubMed Farina L, Chiapparini L, Uziel G, Bugiani M, Zeviani M, Savoiardo M. MR findings in Leigh syndrome with COX deficiency and SURF-1 mutations. AJNR 2002;23:1095–1100.PubMed
43.
Zurück zum Zitat Hirano M, Ricci E, Koenigsberger MR, et al. MELAS: an original case and clinical criteria for diagnosis. Neuromuscular Disord 1992;2:125–135.CrossRef Hirano M, Ricci E, Koenigsberger MR, et al. MELAS: an original case and clinical criteria for diagnosis. Neuromuscular Disord 1992;2:125–135.CrossRef
44.
Zurück zum Zitat Wong LJ. Molecular genetics of mitochondrial disorders. Dev Disabil Res Rev 2010;16:154–162.PubMedCrossRef Wong LJ. Molecular genetics of mitochondrial disorders. Dev Disabil Res Rev 2010;16:154–162.PubMedCrossRef
45.
Zurück zum Zitat Matthews PM, Tampieri D, Berkovic SF, et al. Magnetic resonance imaging shows specific abnormalities in the MELAS syndrome. Neurology 1991;41:1043–1046.PubMedCrossRef Matthews PM, Tampieri D, Berkovic SF, et al. Magnetic resonance imaging shows specific abnormalities in the MELAS syndrome. Neurology 1991;41:1043–1046.PubMedCrossRef
46.
Zurück zum Zitat Castillo M, Kwock L, Green C. MELAS syndrome: imaging and proton MR spectroscopic findings. AJNR 1995;16:233–239.PubMed Castillo M, Kwock L, Green C. MELAS syndrome: imaging and proton MR spectroscopic findings. AJNR 1995;16:233–239.PubMed
47.
Zurück zum Zitat Renard D, Bonnaure H, Labauge P. Teaching neuroImages: diffuse posterior leukoencephalopathy in MELAS without stroke-like episodes. Neurology 2010;75:e9.PubMedCrossRef Renard D, Bonnaure H, Labauge P. Teaching neuroImages: diffuse posterior leukoencephalopathy in MELAS without stroke-like episodes. Neurology 2010;75:e9.PubMedCrossRef
48.
Zurück zum Zitat Finsterer J, Barton P. Regression of stroke-like lesions in MELAS-syndrome after seizure control. Epileptic Disord 2010;12:330–334.PubMed Finsterer J, Barton P. Regression of stroke-like lesions in MELAS-syndrome after seizure control. Epileptic Disord 2010;12:330–334.PubMed
49.
Zurück zum Zitat Ishak GE, Poliakov AV, Poliachik SL, et al. Tract-based spatial statistical analysis of diffusion tensor imaging in pediatric patients with mitochondrial disease: widespread reduction in fractional anisotropy of white matter tracts. AJNR 2012. doi:10.3174/ajnr.A3045. Ishak GE, Poliakov AV, Poliachik SL, et al. Tract-based spatial statistical analysis of diffusion tensor imaging in pediatric patients with mitochondrial disease: widespread reduction in fractional anisotropy of white matter tracts. AJNR 2012. doi:10.​3174/​ajnr.​A3045.
50.
Zurück zum Zitat Brockmann K, Finsterbusch J, Schara U, Wilichowski E, Frahm J, Hanefeld F. Stroke-like pattern in DTI and MRS of childhood mitochondrial leukoencephalopathy. Neuroradiology 2004;46:267–271.PubMedCrossRef Brockmann K, Finsterbusch J, Schara U, Wilichowski E, Frahm J, Hanefeld F. Stroke-like pattern in DTI and MRS of childhood mitochondrial leukoencephalopathy. Neuroradiology 2004;46:267–271.PubMedCrossRef
51.
Zurück zum Zitat Liu Z, Liu X, Hui L, et al. The appearance of ADCs in the non-affected areas of the patients with MELAS. Neuroradiology 2011;53:227–232.PubMedCrossRef Liu Z, Liu X, Hui L, et al. The appearance of ADCs in the non-affected areas of the patients with MELAS. Neuroradiology 2011;53:227–232.PubMedCrossRef
52.
Zurück zum Zitat Clark JM, Marks MP, Adalsteinsson E, et al. MELAS: clinical and pathologic correlations with MRI, xenon/CT, and MR spectroscopy. Neurology 1996;46:223–227.PubMedCrossRef Clark JM, Marks MP, Adalsteinsson E, et al. MELAS: clinical and pathologic correlations with MRI, xenon/CT, and MR spectroscopy. Neurology 1996;46:223–227.PubMedCrossRef
53.
Zurück zum Zitat Feng F, You H, Gao J, et al. Evaluation of mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes with magnetic resonance imaging and proton magnetic resonance spectroscopy. Chin Med Sci J 2006;21:234–238.PubMed Feng F, You H, Gao J, et al. Evaluation of mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes with magnetic resonance imaging and proton magnetic resonance spectroscopy. Chin Med Sci J 2006;21:234–238.PubMed
54.
Zurück zum Zitat Ohama E, Ohara S, Ikuta F, Tanaka K, Nishizawa M, Miyatake T. Mitochondrial angiopathy in cerebral blood vessels of mitochondrial encephalomyopathy. Acta Neuropathol 1987;74:226–233.PubMedCrossRef Ohama E, Ohara S, Ikuta F, Tanaka K, Nishizawa M, Miyatake T. Mitochondrial angiopathy in cerebral blood vessels of mitochondrial encephalomyopathy. Acta Neuropathol 1987;74:226–233.PubMedCrossRef
55.
Zurück zum Zitat Lim BC, Park JD, Hwang H, et al. Mutations in ND subunits of complex I are an important genetic cause of childhood mitochondrial encephalopathies. J Child Neurol 2009;24:828–832.PubMedCrossRef Lim BC, Park JD, Hwang H, et al. Mutations in ND subunits of complex I are an important genetic cause of childhood mitochondrial encephalopathies. J Child Neurol 2009;24:828–832.PubMedCrossRef
56.
Zurück zum Zitat Castro-Gago M, Gonzalez-Conde V, Fernandez-Seara MJ, et al. [Early mitochondrial encephalomyopathy due to complex IV deficiency consistent with Alpers–Huttenlocher syndrome: report of two cases]. Rev Neurol 1999;29:912–917.PubMed Castro-Gago M, Gonzalez-Conde V, Fernandez-Seara MJ, et al. [Early mitochondrial encephalomyopathy due to complex IV deficiency consistent with Alpers–Huttenlocher syndrome: report of two cases]. Rev Neurol 1999;29:912–917.PubMed
57.
Zurück zum Zitat Scaglia F, Towbin JA, Craigen WJ, et al. Clinical spectrum, morbidity, and mortality in 113 pediatric patients with mitochondrial disease. Pediatrics 2004;114:925–931.PubMedCrossRef Scaglia F, Towbin JA, Craigen WJ, et al. Clinical spectrum, morbidity, and mortality in 113 pediatric patients with mitochondrial disease. Pediatrics 2004;114:925–931.PubMedCrossRef
58.
Zurück zum Zitat Scaglia F, Wong LJ, Vladutiu GD, Hunter JV. Predominant cerebellar volume loss as a neuroradiologic feature of pediatric respiratory chain defects. AJNR 2005;26:1675–1680.PubMed Scaglia F, Wong LJ, Vladutiu GD, Hunter JV. Predominant cerebellar volume loss as a neuroradiologic feature of pediatric respiratory chain defects. AJNR 2005;26:1675–1680.PubMed
59.
Zurück zum Zitat Valanne L, Ketonen L, Majander A Suomalainen A, Pihko H. Neuroradiologic findings in children with mitochondrial disorders. AJNR 1998;9:369–377. Valanne L, Ketonen L, Majander A Suomalainen A, Pihko H. Neuroradiologic findings in children with mitochondrial disorders. AJNR 1998;9:369–377.
60.
Zurück zum Zitat Lincke CR, van den Bogert C, Nijtmans LG, Wanders RJ, Tamminga P, Barth PG. Cerebellar hypoplasia in respiratory chain dysfunction. Neuropediatrics 1996;27:216–218.PubMedCrossRef Lincke CR, van den Bogert C, Nijtmans LG, Wanders RJ, Tamminga P, Barth PG. Cerebellar hypoplasia in respiratory chain dysfunction. Neuropediatrics 1996;27:216–218.PubMedCrossRef
61.
Zurück zum Zitat Harding BN. Progressive neuronal degeneration of childhood with liver disease (Alpers–Huttenlocher syndrome): a personal review. J Child Neurol 1990;5:273–287.PubMedCrossRef Harding BN. Progressive neuronal degeneration of childhood with liver disease (Alpers–Huttenlocher syndrome): a personal review. J Child Neurol 1990;5:273–287.PubMedCrossRef
62.
Zurück zum Zitat Hatten HP Jr. Dysmyelinating leukodystrophies: LACK Proper Myelin. Pediatr Radiol 1991;21:477–482.PubMedCrossRef Hatten HP Jr. Dysmyelinating leukodystrophies: LACK Proper Myelin. Pediatr Radiol 1991;21:477–482.PubMedCrossRef
63.
Zurück zum Zitat Finsterer J. Central nervous system imaging in mitochondrial disorders. Can J Neurol Sci 2009;36:143–153.PubMedCrossRef Finsterer J. Central nervous system imaging in mitochondrial disorders. Can J Neurol Sci 2009;36:143–153.PubMedCrossRef
64.
Zurück zum Zitat Saneto RP, Friedman SD, Shaw DW. Neuroimaging of mitochondrial disease. Mitochondrion 2008;8:396–413.PubMedCrossRef Saneto RP, Friedman SD, Shaw DW. Neuroimaging of mitochondrial disease. Mitochondrion 2008;8:396–413.PubMedCrossRef
65.
Zurück zum Zitat Weinstock A, Giglio P, Cohen ME, Bakshi R, Januario J, Balos L. Diffuse magnetic resonance imaging white matter changes in a 15-year-old boy with mitochondrial encephalomyopathy. J Child Neurol 2002;17:47–49.PubMedCrossRef Weinstock A, Giglio P, Cohen ME, Bakshi R, Januario J, Balos L. Diffuse magnetic resonance imaging white matter changes in a 15-year-old boy with mitochondrial encephalomyopathy. J Child Neurol 2002;17:47–49.PubMedCrossRef
66.
Zurück zum Zitat Burgeois M, Goutieres F, Chretien D, Rustin P, Munnich A, Aicardi J. Deficiency in complex II of the respiratory chain, presenting as a leukodystrophy in two sisters with Leigh syndrome. Brain Dev 1992;14:404–408.PubMedCrossRef Burgeois M, Goutieres F, Chretien D, Rustin P, Munnich A, Aicardi J. Deficiency in complex II of the respiratory chain, presenting as a leukodystrophy in two sisters with Leigh syndrome. Brain Dev 1992;14:404–408.PubMedCrossRef
67.
Zurück zum Zitat Nishino I, Spinazzola A, Hirano M. Thymidine phosphorylase gene mutations in MNGIE, a human mitochondrial disorder. Science 1999;283:689–692.PubMedCrossRef Nishino I, Spinazzola A, Hirano M. Thymidine phosphorylase gene mutations in MNGIE, a human mitochondrial disorder. Science 1999;283:689–692.PubMedCrossRef
68.
Zurück zum Zitat Shaibani A, Shchelochkov OA, Zhang S, et al. Mitochondrial neurogastrointestinal encephalopathy due to mutations in RRM2B. Arch Neurol 2009;66:1028–1032.PubMedCrossRef Shaibani A, Shchelochkov OA, Zhang S, et al. Mitochondrial neurogastrointestinal encephalopathy due to mutations in RRM2B. Arch Neurol 2009;66:1028–1032.PubMedCrossRef
69.
Zurück zum Zitat Lebel C, Gee M, Camicioli R, Wieler M, Martin W, Beaulieu C. Diffusion tensor imaging of white matter tract evolution over the lifespan. Neuroimage 2012;60:340–352.PubMedCrossRef Lebel C, Gee M, Camicioli R, Wieler M, Martin W, Beaulieu C. Diffusion tensor imaging of white matter tract evolution over the lifespan. Neuroimage 2012;60:340–352.PubMedCrossRef
70.
Zurück zum Zitat Valanne L, Ketonen L, Majander A, Suomalainen A, Pihko H. Neuroradiologic findings in children with mitochondrial disorders. Am J Neuroradiol 1998;19:369–377.PubMed Valanne L, Ketonen L, Majander A, Suomalainen A, Pihko H. Neuroradiologic findings in children with mitochondrial disorders. Am J Neuroradiol 1998;19:369–377.PubMed
71.
Zurück zum Zitat Wolf NI, Seitz A, Harting I, et al. New pattern f brain MRI lesions in isolated complex deficiency. Neuropediatrics 2003; 34:156–159.PubMedCrossRef Wolf NI, Seitz A, Harting I, et al. New pattern f brain MRI lesions in isolated complex deficiency. Neuropediatrics 2003; 34:156–159.PubMedCrossRef
72.
Zurück zum Zitat Munnich A, Rustin P, Rotig A, et al. Clinical spectrum and diagnosis of mitochondrial disorders. Am J Med Genet (Semin Med Genet) 2001;106:4–17.CrossRef Munnich A, Rustin P, Rotig A, et al. Clinical spectrum and diagnosis of mitochondrial disorders. Am J Med Genet (Semin Med Genet) 2001;106:4–17.CrossRef
73.
Zurück zum Zitat Haas RH, Parikh S, Falk MJ, et al. The indepth evaluation of suspected mitochondrial disease. Mol Genet Metab 208;94:16–37. Haas RH, Parikh S, Falk MJ, et al. The indepth evaluation of suspected mitochondrial disease. Mol Genet Metab 208;94:16–37.
74.
Zurück zum Zitat Walker UA, Collins S, Byrne E. Respiratory chain encephalomyopathies: a diagnostic classification. Eur Neurol 1996;36:260–267.PubMedCrossRef Walker UA, Collins S, Byrne E. Respiratory chain encephalomyopathies: a diagnostic classification. Eur Neurol 1996;36:260–267.PubMedCrossRef
75.
Zurück zum Zitat Wolf NI, Smeitink JA. Mitochondrial disorders: a proposal for consensus diagnostic criteria in infants and children. Neurology 2002;59:1402–1405.PubMedCrossRef Wolf NI, Smeitink JA. Mitochondrial disorders: a proposal for consensus diagnostic criteria in infants and children. Neurology 2002;59:1402–1405.PubMedCrossRef
76.
Zurück zum Zitat Morava E, van den Heuvel L, Hol F, et al. Mitochondrial disease criteria: diagnostic applications in children. Neurology 2006;67:1823–1826.PubMedCrossRef Morava E, van den Heuvel L, Hol F, et al. Mitochondrial disease criteria: diagnostic applications in children. Neurology 2006;67:1823–1826.PubMedCrossRef
77.
Zurück zum Zitat van der Knaap MS, Valk J, de Neeling N, Nauta JJ. Pattern recognition in magnetic resonance imaging of white matter disorders in children and young adults. Neuroradiology 1991;33:478–493.PubMedCrossRef van der Knaap MS, Valk J, de Neeling N, Nauta JJ. Pattern recognition in magnetic resonance imaging of white matter disorders in children and young adults. Neuroradiology 1991;33:478–493.PubMedCrossRef
78.
Zurück zum Zitat Wray SH, Provenzale JM, Johns DR, Thulborn KR. MR of the brain in mitochondrial myopathy. Am J Neuroradiol 1995;16:1167–1173.PubMed Wray SH, Provenzale JM, Johns DR, Thulborn KR. MR of the brain in mitochondrial myopathy. Am J Neuroradiol 1995;16:1167–1173.PubMed
79.
Zurück zum Zitat Cakmakci H, Pekcevik Y, Yis U, Unalp A, Kurul S. Diagnostic value of proton MR spectroscopy and diffusion-weighted MR imaging in childhood inherited neurometabolic brain diseases and review of the literature. Eur J Radiol 2010;74:e161-e171.PubMedCrossRef Cakmakci H, Pekcevik Y, Yis U, Unalp A, Kurul S. Diagnostic value of proton MR spectroscopy and diffusion-weighted MR imaging in childhood inherited neurometabolic brain diseases and review of the literature. Eur J Radiol 2010;74:e161-e171.PubMedCrossRef
80.
Zurück zum Zitat Bernier FP, Boneh A, Dennett X, Chow CW, Clearly MA, Thorburn DR. Diagnostic criteria for respiratory chain disorders in adults and children. Neurology 2002;59:1406–1411. Bernier FP, Boneh A, Dennett X, Chow CW, Clearly MA, Thorburn DR. Diagnostic criteria for respiratory chain disorders in adults and children. Neurology 2002;59:1406–1411.
Metadaten
Titel
Neuroimaging in Mitochondrial Disorders
verfasst von
Andrea L. Gropman
Publikationsdatum
01.04.2013
Verlag
Springer-Verlag
Erschienen in
Neurotherapeutics / Ausgabe 2/2013
Print ISSN: 1933-7213
Elektronische ISSN: 1878-7479
DOI
https://doi.org/10.1007/s13311-012-0161-6

Weitere Artikel der Ausgabe 2/2013

Neurotherapeutics 2/2013 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.